|
|
| (2 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| {{drugbox
| | #REDIRECT [[Capreomycin sulfate]] |
| | IUPAC_name =
| |
| | image = Capreomycin IA.svg
| |
| | image2 = Capreomycin IB.svg
| |
| | CAS_number = 11003-38-6
| |
| | ATC_prefix = J04
| |
| | ATC_suffix = AB30
| |
| | ATC_supplemental =
| |
| | PubChem = 3032400
| |
| | DrugBank = APRD00844
| |
| | C = 25 | H = 44 | N = 14 | O = 8
| |
| | molecular_weight = 668.706 g/mol
| |
| | bioavailability =
| |
| | protein_bound =
| |
| | metabolism =
| |
| | elimination_half-life =
| |
| | pregnancy_category =
| |
| | legal_status =
| |
| | routes_of_administration =
| |
| }}
| |
| {{SI}}
| |
| {{EH}}
| |
| | |
| '''Capreomycin''' is a [[peptide]] [[antibiotic]], commonly grouped with the [[aminoglycoside]]s, which is given in combination with other [[antibiotics]] for [[tuberculosis]]. Adverse effects include [[nephrotoxicity]] and 8th cranial [[neurotoxicity|nerve toxicity]].
| |
| | |
| The drug should not be given with [[streptomycin]] or other drugs that may damage the 8th nerve.
| |
| | |
| {{Antimycobacterials}}
| |
| {{SIB}}
| |
| [[Category:Tuberculosis]]
| |
| [[Category:Aminoglycoside antibiotics]]
| |
| [[es:capreomicina]]
| |
| | |
| {{WH}}
| |
| {{WS}}
| |